Free Trial

ProQR Therapeutics (PRQR) Short Interest Ratio & Short Volume

ProQR Therapeutics logo
$2.63 +0.04 (+1.54%)
(As of 12/20/2024 05:16 PM ET)

ProQR Therapeutics Short Interest Data

ProQR Therapeutics (PRQR) has a short interest of 187,600 shares. This marks a -54.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 533,940 shares to cover all short positions.

Current Short Interest
187,600 shares
Previous Short Interest
413,800 shares
Change Vs. Previous Month
-54.66%
Dollar Volume Sold Short
$720,384.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
81,680,000 shares
Percentage of Shares Shorted
0.23%
Today's Trading Volume
718,766 shares
Average Trading Volume
533,940 shares
Today's Volume Vs. Average
135%
Short Selling ProQR Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ProQR Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PRQR Short Interest Over Time

PRQR Days to Cover Over Time

PRQR Percentage of Float Shorted Over Time

ProQR Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/2024187,600 shares $720,384.00 -54.7%N/A0.1 $3.84
11/15/2024413,800 shares $1.58 million -38.9%N/A0.3 $3.82
10/31/2024677,600 shares $2.37 million +408.3%N/A0.5 $3.50
10/15/2024133,300 shares $241,273.00 -10.5%0.3%0.1 $1.81
9/30/2024148,900 shares $270,998.00 -6.2%0.3%1.1 $1.82
9/15/2024158,700 shares $293,595.00 -4.3%0.3%1.5 $1.85
8/31/2024165,900 shares $335,118.00 -4.5%0.3%1.5 $2.02
8/15/2024173,700 shares $387,351.00 +6.9%0.3%1.5 $2.23
7/31/2024162,500 shares $313,625.00 -5.4%0.3%1.7 $1.93
7/15/2024171,700 shares $300,475.00 -0.9%0.3%1.7 $1.75
6/30/2024173,200 shares $287,512.00 -11.9%0.3%1.5 $1.66
6/15/2024196,600 shares $346,016.00 -18.5%0.4%1.6 $1.76
5/31/2024241,200 shares $470,340.00 +3.7%0.5%1.7 $1.95
5/15/2024232,500 shares $444,075.00 +8.0%0.5%1.5 $1.91
4/30/2024215,300 shares $417,682.00 -10.9%0.4%1.1 $1.94
4/15/2024241,500 shares $493,867.50 -7.5%0.5%1.2 $2.05
3/31/2024261,100 shares $597,892.89 -4.0%0.5%0.9 $2.29
3/15/2024272,100 shares $696,576.00 +3.1%0.5%0.9 $2.56
2/29/2024263,900 shares $533,078.00 -17.3%0.6%0.9 $2.02
2/15/2024319,000 shares $622,050.00 +5.9%0.7%1 $1.95
1/31/2024301,300 shares $653,821.00 -39.1%0.6%0.9 $2.17
1/15/2024494,800 shares $1.10 million -27.3%1.0%1.6 $2.23
12/31/2023680,400 shares $1.35 million -30.7%1.4%3.3 $1.98
12/15/2023981,100 shares $2.11 million +55.8%2.0%4.3 $2.15
11/30/2023629,800 shares $976,190.00 +2.6%1.3%2.9 $1.55
11/15/2023613,600 shares $908,128.00 -9.0%1.2%3.5 $1.48
10/31/2023674,200 shares $775,330.00 -4.5%1.4%3.8 $1.15
10/15/2023705,800 shares $868,134.00 +2.9%1.4%3.7 $1.23
9/30/2023685,900 shares $891,670.00 -24.4%1.4%3.3 $1.30
9/15/2023907,500 shares $1.46 million -3.6%1.8%4.7 $1.61
8/31/2023940,900 shares $1.51 million -2.9%1.7%3.9 $1.61
8/15/2023969,400 shares $1.49 million -16.4%1.8%3.5 $1.54
7/31/20231,160,000 shares $1.74 million +148.1%2.1%3.6 $1.50
7/15/2023467,600 shares $818,300.00 -2.9%0.9%1.3 $1.75
6/30/2023481,300 shares $779,706.00 -8.4%0.9%1.2 $1.62
6/15/2023525,200 shares $892,840.00 -34.0%0.9%0.8 $1.70
5/31/2023796,200 shares $1.39 million -41.9%1.4%1 $1.74
5/15/20231,370,000 shares $2.63 million -33.5%2.5%1.6 $1.92
4/30/20232,060,000 shares $4.49 million -20.2%3.7%2.3 $2.18
4/15/20232,580,000 shares $5.75 million -4.1%4.6%2.6 $2.23
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.
3/31/20232,690,000 shares $5.73 million +66.1%5.1%2.2 $2.13
3/15/20231,620,000 shares $5.02 million +21.8%3.5%0.6 $3.10
2/28/20231,330,000 shares $3.92 million +16.7%2.9%0.5 $2.95
2/15/20231,140,000 shares $3.28 million -23.0%2.5%0.4 $2.88
1/31/20231,480,000 shares $4.08 million -20.0%3.1%0.5 $2.76
1/15/20231,850,000 shares $6.35 million -7.5%3.9%0.6 $3.43
12/30/20222,000,000 shares $7.40 million +102.0%4.2%0.8 $3.70
12/15/2022990,200 shares $1.64 million +0.1%1.7%0.4 $1.66
11/30/2022989,600 shares $1.22 million +44.3%1.7%1.3 $1.23
11/15/2022685,700 shares $654,980.64 -34.7%1.2%1 $0.96
10/31/20221,050,000 shares $971,355.00 -16.0%1.8%1.9 $0.93
10/15/20221,250,000 shares $1.11 million +131.4%2.2%2.6 $0.89
9/30/2022540,300 shares $401,983.20 +54.6%0.9%1.2 $0.74
9/15/2022349,600 shares $276,114.08 +1.7%0.6%0.9 $0.79
8/31/2022343,900 shares $271,646.61 +6.7%0.6%0.8 $0.79
8/15/2022322,300 shares $286,847.00 +3.2%0.6%0.7 $0.89
7/31/2022312,300 shares $261,582.48 -7.1%0.6%0.6 $0.84
7/15/2022336,000 shares $268,800.00 -52.0%0.6%0.5 $0.80
6/30/2022699,900 shares $544,522.20 +33.5%1.2%0.8 $0.78
6/15/2022524,400 shares $399,120.84 -27.4%1.0%0.5 $0.76
5/31/2022722,500 shares $476,850.00 -29.9%1.3%0.7 $0.66
5/15/20221,030,000 shares $638,600.00 -10.4%1.9%0.9 $0.62
4/30/20221,150,000 shares $796,950.00 -28.1%2.1%0.6 $0.69
4/15/20221,600,000 shares $1.26 million +27.0%2.9%0.8 $0.79
3/31/20221,260,000 shares $1.14 million -8.7%2.3%0.7 $0.91
3/15/20221,380,000 shares $1.28 million -31.7%2.5%0.8 $0.93
2/28/20222,020,000 shares $2.16 million -37.5%3.7%1.3 $1.07
2/15/20223,230,000 shares $4.07 million +46.2%5.9%2.2 $1.26
1/31/20222,210,000 shares $12.04 million +82.6%3.9%4.7 $5.45
1/15/20221,210,000 shares $8.18 million +45.2%2.5%3.2 $6.76
12/31/2021833,400 shares $6.68 million +23.7%1.7%2.5 $8.01
12/15/2021673,600 shares $4.75 million +6.4%1.4%1.6 $7.05
11/30/2021633,300 shares $4.47 million -35.5%1.3%0.9 $7.06
11/15/2021981,200 shares $7.61 million -41.9%2.0%1.4 $7.76
10/29/20211,690,000 shares $13.05 million -13.3%3.4%2.4 $7.72
10/15/20211,950,000 shares $15.37 million +8.3%3.9%2.6 $7.88
9/30/20211,800,000 shares $15.07 million -2.7%3.6%2.4 $8.37
9/15/20211,850,000 shares $15.30 million -12.3%3.7%2.7 $8.27
8/31/20212,110,000 shares $14.09 million -9.8%4.0%3.1 $6.68
8/13/20212,340,000 shares $14.72 million +29.3%4.4%4.8 $6.29
7/30/20211,810,000 shares $9.47 million -0.6%3.2%3.6 $5.23
7/15/20211,820,000 shares $10.06 million -4.2%3.4%3.5 $5.53
6/30/20211,900,000 shares $12.81 million +14.5%3.5%3 $6.74
6/15/20211,660,000 shares $12.32 million -15.3%3.1%0.5 $7.42
5/28/20211,960,000 shares $12.23 million -23.7%3.6%0.6 $6.24
5/14/20212,570,000 shares $16.19 million +62.7%N/A0.8 $6.30
4/30/20211,580,000 shares $10.13 million -23.3%N/A0.5 $6.41
4/15/20212,060,000 shares $13.02 million -21.1%N/A0.6 $6.32
3/31/20212,610,000 shares $18.61 million +125.0%N/A0.7 $7.13
3/15/20211,160,000 shares $5.75 million +29.0%N/A1.6 $4.96
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.
2/26/2021899,400 shares $4.09 million -1.3%N/A1.3 $4.55
2/12/2021910,900 shares $4.58 million +4.6%N/A1.4 $5.03
1/29/2021870,800 shares $4.20 million -21.6%N/A1.4 $4.82
1/15/20211,110,000 shares $4.98 million +84.2%N/A2.1 $4.49
12/31/2020602,500 shares $2.51 million -39.1%N/A1.9 $4.17
12/15/2020988,700 shares $4.25 million -16.2%N/A3.3 $4.30
11/30/20201,180,000 shares $4.85 million +45.8%N/A4.7 $4.11
11/15/2020809,200 shares $3.29 million +14.9%N/A3.5 $4.07
10/30/2020704,200 shares $2.69 million +3.7%N/A4.2 $3.82
10/15/2020678,900 shares $3.10 million +2.7%N/A4.1 $4.56
9/30/2020661,100 shares $3.17 million -2.2%N/A4.6 $4.79
9/15/2020676,000 shares $3.56 million -1.7%N/A4.6 $5.27
8/31/2020687,800 shares $4.33 million +0.1%N/A4.5 $6.30
8/14/2020687,000 shares $3.62 million +1.5%N/A4.6 $5.27
7/31/2020676,600 shares $3.50 million +4.6%N/A4.5 $5.17
7/15/2020646,900 shares $3.18 million +2.9%N/A4.2 $4.92
6/30/2020628,500 shares $3.82 million +58.3%N/A4.2 $6.08
6/15/2020397,100 shares $2.08 million +4.2%N/A2.2 $5.25
5/29/2020381,200 shares $2.12 million -21.6%N/A2 $5.56
5/15/2020486,000 shares $2.50 million -9.9%N/A2.4 $5.14
4/30/2020539,100 shares $2.66 million -6.2%N/A2.5 $4.93
4/15/2020575,000 shares $2.86 million -7.0%N/A2.6 $4.97
3/31/2020618,000 shares $3.28 million -10.3%N/A2.7 $5.31
3/13/2020688,800 shares $3.30 million +17.6%2.5%3.5 $4.79
2/28/2020585,800 shares $3.29 million -1.8%2.1%2.5 $5.61
2/14/2020596,300 shares $4.33 million -18.2%N/A2.1 $7.26
1/31/2020729,000 shares $5.44 million -0.3%N/A2.5 $7.46
1/15/2020730,900 shares $6.21 million -31.1%N/A2.5 $8.49
12/31/20191,060,000 shares $8.75 million +8.2%N/A3.2 $8.25

PRQR Short Interest - Frequently Asked Questions

What is ProQR Therapeutics' current short interest?

Short interest is the volume of ProQR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 187,600 shares of PRQR short. Learn More on ProQR Therapeutics' current short interest.

Is ProQR Therapeutics' short interest increasing or decreasing?

ProQR Therapeutics saw a drop in short interest in the month of November. As of November 30th, there was short interest totaling 187,600 shares, a drop of 54.7% from the previous total of 413,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ProQR Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ProQR Therapeutics: Anavex Life Sciences Corp. (23.22%), Immunome, Inc. (19.29%), Kura Oncology, Inc. (11.20%), Keros Therapeutics, Inc. (5.43%), Tyra Biosciences, Inc. (6.79%), Erasca, Inc. (19.73%), Cronos Group Inc. (1.72%), Evolus, Inc. (8.23%), Dianthus Therapeutics, Inc. (29.30%), Rapport Therapeutics (10.25%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short ProQR Therapeutics stock?

Short selling PRQR is an investing strategy that aims to generate trading profit from ProQR Therapeutics as its price is falling. PRQR shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ProQR Therapeutics?

A short squeeze for ProQR Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRQR, which in turn drives the price of the stock up even further.

How often is ProQR Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRQR, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:PRQR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners